According to Agile Therapeutics 's latest financial reports the company's current earnings (TTM) are -$6.6 M. In 2022 the company made an earning of -$4.79 M an increase over its 2021 earnings that were of -$70.98 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$13.05 M | 172.57% |
2022 | -$4.79 M | -93.26% |
2021 | -$70.98 M | 45.62% |
2020 | -$48.75 M | 161.98% |
2019 | -$18.61 M | -2.78% |
2018 | -$19.14 M | -27.47% |
2017 | -$26.39 M | -10.16% |
2016 | -$29.37 M | -14.2% |
2015 | -$34.24 M | 88.45% |
2014 | -$18.17 M | 41.72% |
2013 | -$12.82 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $21.36 B | -324,223.81% | ๐บ๐ธ USA |
Pfizer PFE | $0.89 B | -13,603.26% | ๐บ๐ธ USA |
Merck MRK | $5.11 B | -77,721.00% | ๐บ๐ธ USA |
TherapeuticsMD TXMD | -$6.97 M | 5.70% | ๐บ๐ธ USA |
Antares Pharma ATRS | $65.88 M | -1,099.58% | ๐บ๐ธ USA |